Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension

scientific article published on December 2009

Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/EURHEARTJ/EHP330
P698PubMed publication ID19687162
P5875ResearchGate publication ID26748230

P50authorAlbert FerroQ37843366
Eugenia GkaliagkousiQ92512870
P2093author name stringAshish Shah
Silke Becker
Patricia de Winter
James Ritter
Chrysanthos Zamboulis
Valerie Corrigall
P2860cites workbeta-Actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90Q24305875
Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)Q28209049
Dimethylarginines in chronic renal failureQ28365942
An L-arginine/nitric oxide pathway present in human platelets regulates aggregationQ33674149
Regulation of amino acid and glucose transporters in endothelial and smooth muscle cellsQ35035933
A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane proteinQ35807990
Platelet-derived nitric oxide signaling and regulation.Q36954134
Nitric oxide released from activated platelets inhibits platelet recruitmentQ37369997
Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury.Q42053772
beta(2)-adrenoceptors activate nitric oxide synthase in human plateletsQ42490213
Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregatesQ42514136
1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivoQ42551195
Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinasesQ43261615
Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertensionQ45056027
Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formationQ45345579
Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet functionQ47794972
Cardiovascular disease risk profiles.Q52461317
P433issue24
P304page(s)3048-3054
P577publication date2009-12-01
P1433published inEuropean Heart JournalQ2286839
P1476titleDecreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension
P478volume30

Reverse relations

cites work (P2860)
Q38620927A Central Role for Monocyte-Platelet Interactions in Heart Failure
Q58106881A case of haemorrhagic cystitis by inhaled salbutamol and salmeterol
Q38451947A review and discussion of platelet nitric oxide and nitric oxide synthase: do blood platelets produce nitric oxide from L-arginine or nitrite?
Q50536660Central aortic pulse pressure, thrombogenicity and cardiovascular risk.
Q38586940Clinical Significance of Endothelial Dysfunction in Essential Hypertension.
Q37827566Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.
Q35877953Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1.
Q50117655Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.
Q30407495From hypertension to stroke: mechanisms and potential prevention strategies.
Q53086984Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.
Q35056860Interleukin-1 and acute brain injury
Q34055659Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes
Q37887771Nitric oxide: a guardian for vascular grafts?
Q58551243Papain Ameliorates the MPAs Formation-Mediated Activation of Monocytes by Inhibiting Cox-2 Expression via Regulating the MAPKs and PI3K/Akt Signal Pathway
Q51771267Platelet activation in hypertension associated with hypercholesterolemia: effects of irbesartan.
Q26801407The role of platelets in the recruitment of leukocytes during vascular disease

Search more.